Oncogenic β-catenin stimulation of AKT2-CAD-mediated pyrimidine synthesis is targetable vulnerability in liver cancer

By sjmartinez • September 19, 2022

Liu F, Gai X, Wu Y, Zhang B, Wu X, Cheng R, Tang B, Shang K, Zhao N, Deng W, Chen J, Zhang Z, Gu S, Zheng L, Zhang H. Oncogenic β-catenin stimulation of AKT2-CAD-mediated pyrimidine synthesis is targetable vulnerability in liver cancer. Proc Natl Acad Sci U S A. 2022 Sep 27;119(39):e2202157119. doi: 10.1073/pnas.2202157119. Epub 2022 Sep 19. PMID: 36122209.

Tags: AKT2, CAD, Cardiology/Epi, liver cancer, Publications, pyrimidine synthesis, β-catenin

Immune Checkpoint Inhibitor Myocarditis Masquerading as Brugada Syndrome

Talishinsky A, Bachour K, Lin C, Zakka P, Bassam K, Bull L, Garon E, Krokhaleva Y, Hanna P, Yang EH. Immune Checkpoint Inhibitor Myocarditis Masquerading[...]

Glia of the heart’s nervous system

Scherschel K, Wolf H, Ajijola OA, Shivkumar K, Lindner D, Gomez-Sanchez JA, Meyer C. Glia of the heart's nervous system. Nat Rev Neurosci. 2025 Oct[...]

Association of Component Strategies of the Target Stroke Phase 3 Nationwide Quality Improvement Program With Accelerated Door-to-Puncture and Door-In-Door-Out Times for Ischemic Stroke Endovascular Thrombectomy in the United States

Mac Grory B, Asif KS, Xu H, Alhanti B, Lusk J, Hasan D, Park S, Boehme AK, Zachrison KS, Goyal M, Southerland AM, Jadhav A,[...]